Aveanna Healthcare Holdings Inc. provided revenue guidance for the full year 2022. For the year, the company expects revenue to be in a range of $1,890 million to $1,920 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.485 USD | -9.96% |
|
-0.20% | -7.28% |
05-13 | UBS Adjusts Aveanna Healthcare Price Target to $1.70 From $1.60, Maintains Sell Rating | MT |
05-09 | Transcript : Aveanna Healthcare Holdings Inc., Q1 2024 Earnings Call, May 09, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.28% | 478M | |
+16.42% | 82.53B | |
-26.36% | 73B | |
-0.56% | 26.4B | |
-10.63% | 17.12B | |
+0.25% | 17.09B | |
-0.57% | 15.23B | |
+72.11% | 13.24B | |
+76.39% | 13.02B | |
-24.91% | 12.82B |
- Stock Market
- Equities
- AVAH Stock
- News Aveanna Healthcare Holdings Inc.
- Aveanna Healthcare Holdings Inc. Provides Revenue Guidance for the Full Year 2022